Home Big Pharma: Dealing With Fewer Biotech Targets
 

Keywords :   


Big Pharma: Dealing With Fewer Biotech Targets

2016-01-01 00:50:16| Biotech - Topix.net

There have been 2,000-plus deals over the past two years in pharma and biotech, but the pace isn't likely sustainable The torrid pace of consolidation among drugmakers is bound to slow at some point. But that doesn't mean deal bankers and lawyers will be idle in 2016.

Tags: big dealing fewer targets

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
21.05Eastern North Pacific Tropical Weather Outlook
21.05Atlantic Tropical Weather Outlook
20.05Dantex USA appoints Rob Tolland VP of sales
20.05MDARD designates two bovine tuberculosis testing areas
20.05USDA moves to electronic identification tags
20.05Better pasture and hay conditions anticipated for 2024
20.05Panasonic offers Fire TV, Google TV and Powered by TiVo
20.05Eutelsat reports results for the period ended 31 March 2024
More »